• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

腹膜后淋巴结清扫术治疗非精原细胞瘤性睾丸肿瘤患者

Retroperitoneal lymph node dissection in the treatment of patients with non-seminoma testicular tumours.

作者信息

Kułakowski A, Dardziński R

机构信息

Department of Surgical Oncology, Maria Skłodowska-Curie Memorial Cancer Centre and Institute of Oncology, Warsaw, Poland.

出版信息

Eur J Surg Oncol. 1991 Dec;17(6):581-4.

PMID:1660411
Abstract

Twelve years of experience in performing retroperitoneal lymph node dissection (RPLND) in patients with testicular non-seminomas is presented. One hundred and fifty-two procedures were performed during the years 1977-1989. Seventy-four patients had RPLND prior to chemotherapy and 78 were operated on after the initial chemotherapy. The disparity between the initial staging and intra-operative findings was 35% in the first group and 16% in the second. The mortality rate in both groups was similar (20.3% and 20.5%, respectively). Forty-one of 78 patients operated on after the initial chemotherapy had vital or only partially damaged neoplastic tissue found in the specimen. The diagnostic and therapeutic significance of RPLND is discussed and the importance of the pathological findings in planning postoperative chemotherapy, and in prognosis is stressed.

摘要

本文介绍了对睾丸非精原细胞瘤患者进行腹膜后淋巴结清扫术(RPLND)的12年经验。1977年至1989年期间共进行了152例手术。74例患者在化疗前接受了RPLND,78例在初始化疗后接受了手术。第一组初始分期与术中发现的差异为35%,第二组为16%。两组的死亡率相似(分别为20.3%和20.5%)。78例在初始化疗后接受手术的患者中,有41例在标本中发现有存活或仅部分受损的肿瘤组织。讨论了RPLND的诊断和治疗意义,并强调了病理结果在规划术后化疗和预后方面的重要性。

相似文献

1
Retroperitoneal lymph node dissection in the treatment of patients with non-seminoma testicular tumours.腹膜后淋巴结清扫术治疗非精原细胞瘤性睾丸肿瘤患者
Eur J Surg Oncol. 1991 Dec;17(6):581-4.
2
Long-term oncological outcome after post-chemotherapy retroperitoneal lymph node dissection in men with metastatic nonseminomatous germ cell tumour.化疗后腹膜后淋巴结清扫术治疗转移性非精原细胞瘤生殖细胞肿瘤患者的长期肿瘤学结果。
BJU Int. 2010 Sep;106(6):779-85. doi: 10.1111/j.1464-410X.2009.09175.x. Epub 2010 Jan 19.
3
[Urologic treatment of testicular germ cell cancer].睾丸生殖细胞癌的泌尿外科治疗
Arch Esp Urol. 2002 Oct;55(8):927-36.
4
Post-chemotherapy nerve-sparing retroperitoneal lymph node dissection for advanced germ cell tumor.化疗后保留神经的腹膜后淋巴结清扫术治疗晚期生殖细胞肿瘤
Int J Urol. 2009 Apr;16(4):379-82. doi: 10.1111/j.1442-2042.2009.02251.x. Epub 2009 Feb 3.
5
Adjunctive nephrectomy at post-chemotherapy retroperitoneal lymph node dissection for nonseminomatous germ cell testicular cancer.非精原细胞性生殖细胞睾丸癌化疗后腹膜后淋巴结清扫术中的辅助性肾切除术。
J Urol. 2006 Nov;176(5):1996-9; discussion 1999. doi: 10.1016/j.juro.2006.07.050.
6
[Retroperitoneal lymph node dissection for patients with advanced testicular tumor].[晚期睾丸肿瘤患者的腹膜后淋巴结清扫术]
Hinyokika Kiyo. 1994 Oct;40(10):957-61.
7
Distribution of nodal metastases after chemotherapy in nonseminomatous testis cancer: a possible indication for limited dissection.非精原细胞瘤性睾丸癌化疗后淋巴结转移的分布:有限解剖的可能指征
BJU Int. 2006 Jun;97(6):1221-4. doi: 10.1111/j.1464-410X.2006.06167.x.
8
Repeat retroperitoneal lymph-node dissection after chemotherapy for metastatic testicular germ cell tumour.转移性睾丸生殖细胞肿瘤化疗后重复进行腹膜后淋巴结清扫术。
BJU Int. 2007 Oct;100(4):809-12. doi: 10.1111/j.1464-410X.2007.07087.x. Epub 2007 Aug 17.
9
Retroperitoneal lymph node dissection in patients with low stage testicular cancer with embryonal carcinoma predominance and/or lymphovascular invasion.对以胚胎癌为主和/或存在淋巴管侵犯的低分期睾丸癌患者进行腹膜后淋巴结清扫术。
J Urol. 2005 Aug;174(2):557-60; discussion 560. doi: 10.1097/01.ju.0000165163.03805.37.
10
Morbidity of open retroperitoneal lymph node dissection for testicular cancer: contemporary perioperative data.开放腹膜后淋巴结清扫术治疗睾丸癌的发病率:当代围手术期数据。
BJU Int. 2010 Apr;105(7):918-21. doi: 10.1111/j.1464-410X.2009.08888.x. Epub 2009 Aug 28.

引用本文的文献

1
Is modified retroperitoneal lymph node dissection (MRLND) still feasible in the treatment of patients with clinical stage I non-seminomatous testicular cancer?改良腹膜后淋巴结清扫术(MRLND)在治疗临床I期非精原细胞瘤性睾丸癌患者中是否仍然可行?
Int Urol Nephrol. 1994;26(4):471-7. doi: 10.1007/BF02768020.